Literature DB >> 26973104

Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.

Jacqueline E Maye1, Rebecca A Betensky2, Christopher M Gidicsin3, Joseph Locascio4, J Alex Becker3, Lesley Pepin3, Jeremy Carmasin5, Dorene M Rentz6, Gad A Marshall6, Deborah Blacker7, Reisa A Sperling6, Keith A Johnson8.   

Abstract

Family history (FH) of dementia is a major risk factor for Alzheimer's disease, particularly when the FH is maternal and when the age of dementia onset (AO) is younger. This study tested whether brain amyloid-beta deposition, measured in vivo with (11)C-Pittsburgh compound B (PiB), was associated with parental dementia and/or younger parental AO. Detailed FH and positron emission tomography (PiB) data were acquired in 147 nondemented aging individuals (mean age 75 ± 8). No participant had both positive maternal and paternal FH. A series of analyses revealed that those with maternal, but not paternal, FH had greater levels of PiB retention in a global cortical region than those without FH. PiB retention in maternal FH was not significantly greater than paternal FH. Younger maternal dementia AO was related to greater PiB retention in offspring, whereas younger paternal dementia AO was not. Overall, results suggest that not only is amyloid-beta burden greater in individuals with maternal FH, but also that the burden is greater in association with younger maternal AO.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid-beta; Family history; PET; PiB

Mesh:

Substances:

Year:  2015        PMID: 26973104      PMCID: PMC4792089          DOI: 10.1016/j.neurobiolaging.2015.12.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  53 in total

1.  Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance.

Authors:  S D Edland; J M Silverman; E R Peskind; D Tsuang; E Wijsman; J C Morris
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

2.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

3.  Variability of familial risk of Alzheimer disease across the late life span.

Authors:  Jeremy M Silverman; Gregory Ciresi; Christopher J Smith; Deborah B Marin; Michal Schnaider-Beeri
Journal:  Arch Gen Psychiatry       Date:  2005-05

4.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

5.  Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease.

Authors:  D Ehrenkrantz; J M Silverman; C J Smith; S Birstein; D Marin; R C Mohs; K L Davis
Journal:  Am J Med Genet       Date:  1999-08-20

Review 6.  Sex, hormones, and Alzheimer's disease.

Authors:  Larry W Baum
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-06       Impact factor: 6.053

7.  Conjugal Alzheimer's disease: is there an increased risk in offspring?

Authors:  T D Bird; E J Nemens; W A Kukull
Journal:  Ann Neurol       Date:  1993-09       Impact factor: 10.422

8.  Assessment of genetic risk for Alzheimer's disease among first-degree relatives.

Authors:  L A Farrer; D M O'Sullivan; L A Cupples; J H Growdon; R H Myers
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

9.  Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?

Authors:  N T Lautenschlager; L A Cupples; V S Rao; S A Auerbach; R Becker; J Burke; H Chui; R Duara; E J Foley; S L Glatt; R C Green; R Jones; H Karlinsky; W A Kukull; A Kurz; E B Larson; K Martelli; A D Sadovnick; L Volicer; S C Waring; J H Growdon; L A Farrer
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

10.  Resourceful imprinting.

Authors:  Miguel Constância; Gavin Kelsey; Wolf Reik
Journal:  Nature       Date:  2004-11-04       Impact factor: 49.962

View more
  5 in total

1.  Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.

Authors:  Rachel F Buckley; Elizabeth C Mormino; Rebecca E Amariglio; Michael J Properzi; Jennifer S Rabin; Yen Ying Lim; Kathryn V Papp; Heidi I L Jacobs; Samantha Burnham; Bernard J Hanseeuw; Vincent Doré; Annette Dobson; Colin L Masters; Michael Waller; Christopher C Rowe; Paul Maruff; Michael C Donohue; Dorene M Rentz; Dylan Kirn; Trey Hedden; Jasmeer Chhatwal; Aaron P Schultz; Keith A Johnson; Victor L Villemagne; Reisa A Sperling
Journal:  Alzheimers Dement       Date:  2018-05-24       Impact factor: 21.566

2.  Linear Regression with a Randomly Censored Covariate: Application to an Alzheimer's Study.

Authors:  Folefac D Atem; Jing Qian; Jacqueline E Maye; Keith A Johnson; Rebecca A Betensky
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2016-06-27       Impact factor: 1.864

3.  Parental History of Dementia Is Associated with Increased Small Vessel Cerebrovascular Disease.

Authors:  Bessie C Stamm; Patrick J Lao; Batool Rizvi; Juliet Colon; Kay Igwe; Anthony G Chesebro; Benjamin Maas; Nicole Schupf; Richard Mayeux; Jennifer J Manly; Adam M Brickman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-10-15       Impact factor: 6.053

4.  Threshold regression to accommodate a censored covariate.

Authors:  Jing Qian; Sy Han Chiou; Jacqueline E Maye; Folefac Atem; Keith A Johnson; Rebecca A Betensky
Journal:  Biometrics       Date:  2018-06-22       Impact factor: 2.571

5.  The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.

Authors:  Kyoung Shin Park; Alexis B Ganesh; Nathaniel T Berry; Yashonda P Mobley; William B Karper; Jeffrey D Labban; Christopher N Wahlheim; Tomika M Williams; Laurie Wideman; Jennifer L Etnier
Journal:  BMC Neurol       Date:  2020-06-06       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.